Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial

Fig. 3

Anti-6C and anti-R0.6C IgG antibody responses over time. A Geometric mean anti-R0.6C antibody concentrations per study arm. B Geometric mean anti-6C antibody concentrations per study arm. C Geometric mean IgG responses against 6C as a fraction of total IgG responses against R0.6C per study arm. IgG concentrations in A and B are calculated using serially diluted anti-6C antibody TB31F of known concentration as a reference. Arrows represent vaccinations. Error bars indicate 95% CI. Dashed lines indicate the geometric mean of pre-immunisation (baseline) serum samples

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us